CAROLE SUE BEN-MAIMON
Medical Practice in Merion Station, PA
License number
Pennsylvania MD037840E
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
Merion Station, PA 19066
Personal information
See more information about CAROLE SUE BEN-MAIMON at radaris.comName
Address
Phone
Merion Station, PA
359 Brookway Rd, Merion Station, PA 19066
Professional information
Vaginal Cream Compositions, Kits Thereof And Methods Of Using Thereof
US Patent:
2008007, Mar 20, 2008
Filed:
Aug 17, 2007
Appl. No.:
11/892012
Inventors:
Salah Ahmed - New City NY, US
Charles Diliberti - Montclair NJ, US
Carole Ben-Maimon - Merion PA, US
Howard Hait - Wilmington DE, US
Charles Diliberti - Montclair NJ, US
Carole Ben-Maimon - Merion PA, US
Howard Hait - Wilmington DE, US
International Classification:
A61K 31/566, A61P 15/02
US Classification:
514178000, 514182000
Abstract:
The present invention is directed to pharmaceutical vaginal cream compositions comprising a conjugated estrogen and a stabilizer. The present invention is also directed to a method of treating a menopausal condition in a female in need thereof, said method comprising vaginally administering a pharmaceutical vaginal cream composition comprising a conjugated estrogen twice per week for at least 2 weeks.
Methods Of Hormonal Treatment Utilizing Contraceptive Regimens With Continuous Estrogen Administration
US Patent:
2011012, May 26, 2011
Filed:
Oct 26, 2010
Appl. No.:
12/912583
Inventors:
ROBERT G. BELL - PALM HARBOR FL, US
CAROLE S. BEN-MAIMON - MERION PA, US
BEATA ISKOLD - LIVINGSTON NJ, US
LANCE J. BRONNENKANT - SNYDER NY, US
HOWARD HAIT - WILMINGTON DE, US
KATHLEEN Z. REAPE - Bryn Mawr PA, US
CAROLE S. BEN-MAIMON - MERION PA, US
BEATA ISKOLD - LIVINGSTON NJ, US
LANCE J. BRONNENKANT - SNYDER NY, US
HOWARD HAIT - WILMINGTON DE, US
KATHLEEN Z. REAPE - Bryn Mawr PA, US
Assignee:
TEVA WOMEN'S HEALTH, INC. - WOODCLIFF LAKE NJ
International Classification:
A61K 31/56, A61P 5/00, A61P 19/02, A61P 3/10, A61P 25/08, A61P 25/06
US Classification:
514170
Abstract:
The present invention provides contraceptive regimens in which a female is administered a combined dosage form of estrogen and progestin followed by a period of administration of estrogen. The disclosed contraceptive regimens can be administered to a female as a method of providing non-contraceptive benefits.
Oral Contraceptives To Prevent Pregnancy And Diminish Premenstrual Symptomatology
US Patent:
7615545, Nov 10, 2009
Filed:
Aug 17, 2007
Appl. No.:
11/892014
Inventors:
Robert G. Bell - Palm Harbor FL, US
Carole Ben-Maimon - Merion PA, US
Beata Iskold - Livingston NJ, US
Carole Ben-Maimon - Merion PA, US
Beata Iskold - Livingston NJ, US
Assignee:
Duramed Pharmaceuticals, Inc. - Pomona NY
International Classification:
A61K 31/56, A61K 31/135
US Classification:
514170, 514171, 514649
Abstract:
This invention relates to a method of preventing pregnancy and treating PMS including PMDD. More particularly, the invention relates to a method, which involves administering one of several combination oral contraceptive regimens in combination with an antidepressant and a kit containing the same.
Vaginal Cream Compositions, Kits Thereof And Methods Of Using Thereof
US Patent:
2006004, Feb 23, 2006
Filed:
Aug 17, 2004
Appl. No.:
10/919529
Inventors:
Salah Ahmed - New City NY, US
Charles Diliberti - Montclair NJ, US
Carole Ben-Maimon - Merion PA, US
Howard Hait - Wilmington DE, US
Charles Diliberti - Montclair NJ, US
Carole Ben-Maimon - Merion PA, US
Howard Hait - Wilmington DE, US
International Classification:
A61K 31/56
US Classification:
514182000
Abstract:
The present invention is directed to pharmaceutical vaginal cream compositions comprising a conjugated estrogen and a stabilizer. The present invention is also directed to a method of treating a menopausal condition in a female in need thereof, said method comprising vaginally administering a pharmaceutical vaginal cream composition comprising a conjugated estrogen twice per week for at least 2 weeks.
Oral Contraceptives To Prevent Pregnancy And Diminish Premenstrual Symptomatology
US Patent:
2012032, Dec 20, 2012
Filed:
Aug 30, 2012
Appl. No.:
13/600050
Inventors:
Robert G. Bell - Palm Harbor FL, US
Carole Ben-Maimon - Merion Station PA, US
Beata Iskold - Livingston NJ, US
Carole Ben-Maimon - Merion Station PA, US
Beata Iskold - Livingston NJ, US
International Classification:
A61K 31/56, A61P 25/24, A61P 15/18
US Classification:
514170
Abstract:
This invention relates to a method of preventing pregnancy and treating PMS including PMDD. More particularly, the invention relates to a method, which involves administering one of several combination oral contraceptive regimens in combination with an antidepressant and a kit containing the same.
Oral Contraceptives To Prevent Pregnancy And Diminish Premenstrual Symptomatology
US Patent:
2003013, Jul 24, 2003
Filed:
Dec 4, 2002
Appl. No.:
10/309313
Inventors:
Robert Bell - Palm Harbor FL, US
Carole Ben-Maimon - Merion PA, US
Beata Iskold - Livingston NJ, US
Carole Ben-Maimon - Merion PA, US
Beata Iskold - Livingston NJ, US
Assignee:
Barr Laboratories, Inc.
International Classification:
A61K031/56, A61K031/137
US Classification:
514/170000, 514/649000
Abstract:
This invention relates to a method of preventing pregnancy and treating PMS including PMDD. More particularly, the invention relates to a method, which involves administering one of several combination oral contraceptive regimens in combination with an antidepressant and a kit containing the same.
Oral Contraceptives To Prevent Pregnancy And Diminish Premenstrual Symptomatology
US Patent:
8338396, Dec 25, 2012
Filed:
May 24, 2010
Appl. No.:
12/786283
Inventors:
Robert G. Bell - Palm Harbor FL, US
Carole Ben-Maimon - Merion PA, US
Beata Iskold - Livingston NJ, US
Carole Ben-Maimon - Merion PA, US
Beata Iskold - Livingston NJ, US
Assignee:
Teva Women's Health, Inc. - Woodcliff Lake NJ
International Classification:
A61K 31/56
US Classification:
514170, 514182, 514171
Abstract:
This invention relates to a method of preventing pregnancy and treating PMS including PMDD. More particularly, the invention relates to a method, which involves administering one of several combination oral contraceptive regimens in combination with an antidepressant and a kit containing the same.
Methods For Treating Vasomotor Symptoms In Castrated Prostatic Cancer Patients With Low Dose Cyproterone Acetate
US Patent:
8288342, Oct 16, 2012
Filed:
Oct 12, 2009
Appl. No.:
12/577600
Inventors:
Salah U. Ahmed - New City NY, US
Sundeep Sethia - Suffern NY, US
Kathleen Reape - Newtown Square NY, US
Howard Hait - Wilmington DE, US
Carole S. Ben-Maimon - Merion PA, US
Sundeep Sethia - Suffern NY, US
Kathleen Reape - Newtown Square NY, US
Howard Hait - Wilmington DE, US
Carole S. Ben-Maimon - Merion PA, US
Assignee:
Teva Women's Health, Inc. - Woodcliff Lake NJ
International Classification:
A61P 5/26
US Classification:
514 102, 424451, 424464, 424489, 514 195, 514178
Abstract:
The present invention is directed to methods of treating vasomotor symptoms in castrated prostatic cancer patients in need of treatment, comprising administering about 15 mg or less of cyproterone acetate per day to the patients. The present invention is further directed to dosage forms comprising about 1 mg to about 15 mg of cyproterone acetate and a package comprising a plurality of dosage forms comprising about 1 mg to about 15 mg of cyproterone acetate.
Oral Contraceptives To Prevent Pregnancy And Diminish Premenstrual Symptomatology
US Patent:
7858605, Dec 28, 2010
Filed:
Dec 6, 2007
Appl. No.:
11/951492
Inventors:
Robert G. Bell - Palm Harbor FL, US
Carole Ben-Maimon - Merion PA, US
Beata Iskold - Livingston NJ, US
Carole Ben-Maimon - Merion PA, US
Beata Iskold - Livingston NJ, US
Assignee:
Teva Women's Health, Inc. - Woodcliff Lake NJ
International Classification:
A61K 31/56
US Classification:
514170
Abstract:
This invention relates to a method of preventing pregnancy and treating PMS including PMDD. More particularly, the invention relates to a method, which involves administering one of several combination oral contraceptive regimens in combination with an antidepressant and a kit containing the same.
Methods Of Hormonal Treatment Utilizing Contraceptive Regimens With Continuous Estrogen Administration
US Patent:
7855190, Dec 21, 2010
Filed:
Jul 16, 2004
Appl. No.:
10/892404
Inventors:
Robert G. Bell - Palm Harbor FL, US
Carole S. Ben-Maimon - Merion PA, US
Beata Iskold - Livingston NJ, US
Lance J. Bronnenkant - Snyder NY, US
Howard Hait - Wilmington DE, US
Kathleen Z. Reape - Bryn Mawr PA, US
Carole S. Ben-Maimon - Merion PA, US
Beata Iskold - Livingston NJ, US
Lance J. Bronnenkant - Snyder NY, US
Howard Hait - Wilmington DE, US
Kathleen Z. Reape - Bryn Mawr PA, US
Assignee:
Teva Women's Health, Inc. - Woodcliff Lake NJ
International Classification:
A01N 45/00, A61K 31/56
US Classification:
514170, 514171, 514182
Abstract:
The present invention provides contraceptive regimens in which a female is administered a combined dosage form of estrogen and progestin followed by a period of administration of estrogen. The disclosed contraceptive regimens can be administered to a female as a method of providing non-contraceptive benefits.